Genmab A/SGMABNASDAQ
Loading
Operating Margin Over TimeStable
Percentile Rank43
3Y CAGR-8.0%
5Y CAGR-11.7%
Studio
Year-over-Year Change

Operating income as a percentage of revenue

3Y CAGR
-8.0%/yr
vs -1.4%/yr prior
5Y CAGR
-11.7%/yr
Recent acceleration
Acceleration
-6.7pp
Decelerating
Percentile
P43
Within normal range
vs 5Y Ago
0.5x
Contraction
Streak
1 yr
Consecutive growthStable
PeriodValueYoY Change
202533.60%+7.9%
202431.14%-3.6%
202332.30%-25.2%
202243.21%+23.2%
202135.08%-43.8%
202062.44%+27.0%
201949.16%+7.7%
201845.63%-19.7%
201756.83%-2.0%
201657.97%-